Archives
Anti-virus software sector investigation latest
Here’s the latest in the important anti-virus software sector investigation that’s being conducted by the CMA (Competition and Markets Authority).
It’s an important one, especially given how prevalent cybersecurity is these days. There have been so many hacks and attacks in recent times that all organisations – both public and private sector – must invest properly to ensure that they’re defended.
But are service providers in the sector offering their vital line of defence in terms that are deemed as fair, and in the spirit of healthy competition? That’s essentially what the CMA wants to find out.
Loyalty penalty investigation: the latest
There has been an update about some of the positive steps that have been taken in the wake of the huge loyalty penalty investigation, often referred to as a “super complaint”.
A “super complaint” is a complaint that’s usually submitted by a consumer body on behalf of a number of people who have the same complaint against sometimes several companies, and sometimes across more than one sector. The loyalty penalty super complaint stemmed from the Citizens Advice Bureau who had raised concerns over customers paying more for goods and services for sticking with the same suppliers.
This one has covered notable areas that include insurance, mortgages, bank accounts, broadband services and mobile services.
Anti-competitive agreements for pharmaceutical drugs: statement of objections issued
In the latest investigation into suspected anti-competitive agreements for pharmaceutical drugs, a statement of objections has been issued by the CMA (Competition and Markets Authority).
The statement was issued last month and relates to a number of pharmaceutical companies who stand accused of participating in anti-competitive behaviour. Whether it’s a case of formal agreements in place, or concerted practices, the issue surrounds the supply of 50mg and 100mg nitrofurantoin capsules in the UK.
This investigation by the CMA into the practices of pharmaceutical firms is one of many that have been ongoing for a number of years. They’re one of the most important areas the CMA needs to safeguard.
Barchester consumer protection case
The Competition and Markets Authority (CMA) is taking action in the Barchester consumer protection case under the pretence that consumer laws may have been broken.
The wider action surrounding care homes in the UK has been going on for over two years now, and we recently reported about the court action launched against Care UK.
Now, the CMA has sent a letter before action to Barchester Healthcare Limited, Barchester Healthcare Homes Limited, Grove Limited and Barchester Holdco (Jersey) Limited; known altogether as ‘Barchester’. It’s alleged that certain fees that have been charged contravene consumer protection laws.
The ongoing Viagogo court case between the Competition and Markets Authority (CMA) and the secondary ticketing website is about to step up.
The CMA are reportedly moving ahead with contempt of court proceedings on the basis that they say Viagogo is still failing to adhere to a court order obtained earlier this year.
This is huge news, and it’s alarming to hear that the CMA considers that the ticketing resellers are still failing to comply with a court order. Following a market sector review, a number of firms changed their behaviours, but it appears that Viagogo isn’t fully complying.
CMA anti-virus software investigation latest
The CMA anti-virus software investigation was launched back in December 2018, and the consumer regulator has been looking into whether renewal practices are legally compliant.
This investigation was a part of the wider loyalty penalty super complaint. With both personal and business reliance on anti-virus software prevalent, this is a huge market sector where there’s a need to ensure that consumer law is always being adhered to.
In the most recent update, the CMA (Competition and Markets Authority) has provided a little more insight into what they’re focusing on as part of their market review.
Office design and fit-out cartel leads to director disqualifications
The CMA (Competition and Markets Authority) has secured the disqualification of a number of directors in the aftermath of the fines issued in the office design and fit-out cartel investigation.
In April 2019, fines in the sum of £7m were issued to a number of companies who had been found guilty of breaking vital competition laws. For over a decade, the guilty companies had been engaging in cover bidding, where they were able to artificially inflate the prices of at least 14 contracts. This kind of behaviour can also reduce the quality of services on offer for the consumer as well.
Now, the CMA has taken further action by securing disqualifications for a number of directors who were involved in the cartel activity.
Groundworks supplier investigation: the latest
There’s an ongoing groundworks supplier investigation being conducted by the Competition and Markets Authority (CMA), so here’s the latest.
The investigation surrounds suspicions of anti-competitive behaviour in the sector for the supply of groundworks products to the construction industry. The CMA’s investigation is looking into whether any of the key suppliers in the market are breaching important competition laws. If they are found to be acting unethically, they could face substantial fines.
The investigation has been going on for some time now, and a great deal of evidence has been collected and reviewed so far.
Provisional finding in the pharmaceuticals competition investigation
There has been a provisional finding in the pharmaceuticals competition investigation by the Competition and Markets Authority (CMA) who have been looking into companies for quite some time.
It has been alleged that anti-competitive agreements are in place between four firms in the sector, and the calculated costs to the NHS is terrifying. If the provisional finding is formalised, huge fines could be issued to the alleged offenders involved in the investigation.
The costs of anti-competitive arrangements in the pharmaceutical industry often fall on the NHS, and therefore on the taxpayer, which is why these kinds of investigations are incredibly important.
End of contract alerts to be initiated in the UK
We welcome the move to enforce end of contract alerts, which is set to put the consumer firmly back behind the steering wheel when it comes to their contracts for key services.
From February 2020, broadband, phone and TV companies will have to notify their customers when they’re close to the expiry date of their contract. They’ll also have to provide information about pricing and better deals they can offer, as well as clearer information about how to cancel.
The move is aimed to stop consumers aimlessly walking into new contracts and not knowing when their current term has elapsed. This ties in with the loyalty penalty super complaint, and is designed to make sure the consumer is put first.